1. Home
  2. ZSPC vs AQST Comparison

ZSPC vs AQST Comparison

Compare ZSPC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZSPC
  • AQST
  • Stock Information
  • Founded
  • ZSPC 2007
  • AQST 2004
  • Country
  • ZSPC United States
  • AQST United States
  • Employees
  • ZSPC N/A
  • AQST N/A
  • Industry
  • ZSPC
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZSPC
  • AQST Health Care
  • Exchange
  • ZSPC NYSE
  • AQST Nasdaq
  • Market Cap
  • ZSPC 340.9M
  • AQST 274.4M
  • IPO Year
  • ZSPC 2024
  • AQST 2018
  • Fundamental
  • Price
  • ZSPC $8.78
  • AQST $3.04
  • Analyst Decision
  • ZSPC Strong Buy
  • AQST Strong Buy
  • Analyst Count
  • ZSPC 3
  • AQST 6
  • Target Price
  • ZSPC $13.67
  • AQST $11.17
  • AVG Volume (30 Days)
  • ZSPC 72.4K
  • AQST 1.4M
  • Earning Date
  • ZSPC 05-15-2025
  • AQST 05-06-2025
  • Dividend Yield
  • ZSPC N/A
  • AQST N/A
  • EPS Growth
  • ZSPC N/A
  • AQST N/A
  • EPS
  • ZSPC 1.03
  • AQST N/A
  • Revenue
  • ZSPC $38,098,000.00
  • AQST $57,561,000.00
  • Revenue This Year
  • ZSPC $28.38
  • AQST N/A
  • Revenue Next Year
  • ZSPC $45.23
  • AQST $39.51
  • P/E Ratio
  • ZSPC $8.55
  • AQST N/A
  • Revenue Growth
  • ZSPC N/A
  • AQST 13.79
  • 52 Week Low
  • ZSPC $5.25
  • AQST $2.24
  • 52 Week High
  • ZSPC $32.69
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • ZSPC N/A
  • AQST 51.97
  • Support Level
  • ZSPC N/A
  • AQST $3.05
  • Resistance Level
  • ZSPC N/A
  • AQST $3.24
  • Average True Range (ATR)
  • ZSPC 0.00
  • AQST 0.19
  • MACD
  • ZSPC 0.00
  • AQST 0.01
  • Stochastic Oscillator
  • ZSPC 0.00
  • AQST 48.53

About ZSPC ZSPACE INC

ZSPACE Inc is a provider of augmented reality (AR) and virtual reality (VR) educational technology solutions. It focus on both United States K-12 schools and Career & Technical Education (CTE) markets. The company's proprietary hardware and software platform provides the ability to deliver an interactive, stereoscopic three-dimensional (3D) learning experience to users without the need to utilize VR goggles or specialty glasses. The platform serves a broad range of critical educational tools designed for K-12 science, technology, engineering and math (STEM) lessons as well as training skilled trades in areas such as health sciences, automotive engineering/repair, Unity3D software programming and manufacturing. Key revenue is generated from hardware.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Share on Social Networks: